Search results
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 3 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
Vertex stock target lifted, retains Outperform on pain management drug potential By Investing.com
Investing.com· 3 days agoOn Friday, BMO Capital Markets adjusted its outlook on Vertex Pharmaceuticals (NASDAQ:VRTX)...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 3 days agoEli Lilly (LLY), Novo Nordisk (NVO), Vertex Pharmaceuticals (VRTX), Intuitive Surgical (ISRG) and...
5 Top Stocks to Buy in June
Motley Fool via Yahoo Finance· 2 days agoThese Motley Fool contributors are particularly excited about SoundHound AI (NASDAQ: SOUN), Adobe (NASDAQ: ADBE), Vertex Pharmaceuticals (NASDAQ: VRTX),...
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
Zacks· 5 days agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Dow Jones Falls, S&P Reverses Lower As Warren Buffett Stock 'Plunges' 99%; GameStop Soars Amid...
Investor's Business Daily· 8 hours agoThe Dow Jones Industrial Average fell further at midday while trading in stocks including Berkshire...
Vertex Pharmaceuticals, Inc. (VRTX) gets rating Upgrade from Evercore ISI – Knox Daily
Knox Daily· 7 days agoVertex Pharmaceuticals, Inc.’s recently made public that its Director SACHS BRUCE I unloaded Company’s shares for reported $3.17 million on May 22 ’24.
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 6 days agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoMeanwhile, the pharma group ranks No. 139. But it's key to watch specific measures when examining...
Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday? - Arcturus Therapeutics (NASDAQ:ARCT)
Benzinga· 6 days agoOn Tuesday, Arcturus Therapeutics Holdings Inc. ARCT announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at ...